Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Journal: Nature

Published: 2020-05-14

DOI: 10.1038/s41586-020-2332-7

Affiliations: 6

Authors: 8

Go to article
Institutions Share
Institute of Medical Virology, GU, Germany 0.44
Institute of Biochemistry II (IBCII), GU, Germany 0.29
University Hospital Frankfurt, GU, Germany 0.13
DZHK Partner Site Rhine-Main, Germany 0.06
Frankfurt Cancer Institute (FCI), Germany 0.04
Cluster of Excellence - The Cardio-Pulmonary Institute (CPI), Germany 0.04

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER